Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Yaron Werber is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/17/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/15/2024 | LEGN | Buy Now | Legend Biotech | $55.84 | 19.99% | $71 → $67 | Maintains | Buy | Get Alert |
| 06/25/2024 | ASND | Buy Now | Ascendis Pharma | $140.80 | 24.29% | $156 → $175 | Upgrade | Hold → Buy | Get Alert |
| 05/09/2024 | BGNE | Buy Now | BeiGene | $152.92 | 66.1% | $236 → $254 | Maintains | Buy | Get Alert |
| 05/07/2024 | BNTX | Buy Now | BioNTech | $86.96 | 12.7% | $95 → $98 | Maintains | Hold | Get Alert |
| 05/01/2024 | EXEL | Buy Now | Exelixis | $22.76 | 18.63% | $25 → $27 | Maintains | Buy | Get Alert |
| 04/24/2024 | BGNE | Buy Now | BeiGene | $152.92 | 54.33% | $235 → $236 | Maintains | Buy | Get Alert |
| 04/24/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $45.27 | 34.75% | $59 → $61 | Maintains | Buy | Get Alert |
| 03/26/2024 | STOK | Buy Now | Stoke Therapeutics | $14.74 | — | — | Upgrade | Hold → Buy | Get Alert |
| 03/18/2024 | JSPR | Buy Now | Jasper Therapeutics | $21.61 | — | — | Initiates | → Outperform | Get Alert |
| 03/15/2024 | IMRX | Buy Now | Immuneering | $1.26 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/31/2024 | TSVT | Buy Now | 2seventy bio | $4.91 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/20/2023 | CLDX | Buy Now | Celldex Therapeutics | $40.11 | — | — | Initiates | → Outperform | Get Alert |
| 12/12/2023 | ARGX | Buy Now | argenx | $471.80 | 35.86% | $612 → $641 | Maintains | Outperform | Get Alert |
| 10/19/2023 | GBIO | Buy Now | Generation Bio | $3.19 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/28/2023 | BNTX | Buy Now | BioNTech | $86.96 | 49.49% | $145 → $130 | Maintains | Market Perform | Get Alert |
| 02/28/2023 | FGEN | Buy Now | FibroGen | $1.14 | 2092.98% | $15 → $25 | Maintains | Market Perform | Get Alert |
| 01/25/2023 | ARGX | Buy Now | argenx | $471.80 | -2.92% | $441 → $458 | Maintains | Outperform | Get Alert |
| 11/01/2022 | LEGN | Buy Now | Legend Biotech | $55.84 | — | — | Initiates | → Outperform | Get Alert |
| 11/01/2022 | TIL | Buy Now | Instil Bio | $13.23 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/02/2022 | GMAB | Buy Now | Genmab | $26.64 | 42.64% | → $38 | Initiates | → Market Perform | Get Alert |
| 04/06/2022 | BLUE | Buy Now | bluebird bio | $1.32 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/31/2022 | ORTX | Buy Now | Orchard Therapeutics | — | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/06/2022 | ASND | Buy Now | Ascendis Pharma | $140.80 | -3.41% | → $136 | Initiates | → Market Perform | Get Alert |
| 01/06/2022 | TSVT | Buy Now | 2seventy bio | $4.91 | — | — | Initiates | → Outperform | Get Alert |
| 11/30/2021 | IOBT | Buy Now | IO Biotech | $1.32 | — | — | Initiates | → Outperform | Get Alert |
